| Name | acethylshikonin |
|---|---|
| Synonyms |
shikonin acetate
1'O-acetylshikonin 2-[1-(acetyloxy)-4-methyl-3-pentenyl]naphthazarin acetyl shikonin 1,4-Naphthalenedione,2-(1-(acetyloxy)-4-methyl-3-pentenyl)-5,8-dihydroxy |
| Description | DL-Acetylshikonin is a non-selective, reversible Cytochrome P450 inhibitor with IC50 values of 1.4-4.0 μM. DL-Acetylshikonin has anti-cancer and anti-inflammatory activities[1]. |
|---|---|
| Related Catalog | |
| Target |
CYP2C8:1.4 μM (IC50) CYP2B6:2.0 μM (IC50) CYP3A:2.3 μM (IC50) CYP2C19:2.5 μM (IC50) CYP2D6:2.5 μM (IC50) CYP2E1:2.7 μM (IC50) CYP2C9:3.3 μM (IC50) CYP2J2:3.3 μM (IC50) CYP2A6:3.8 μM (IC50) CYP1A2:4.0 μM (IC50) |
| In Vitro | DL-Acetylshikonin 抑制 CYP3A 介导的睾酮 (testosterone) 和 Nifedipine (HY-B0284) 代谢,IC50 值分别为 5.2 μM 和 3.0 μM,表明其以不依赖底物的方式抑制 CYP3A 活性[1]。 DL-Acetylshikonin 不是一种时间依赖性抑制剂[1]。 |
| References |
| Molecular Formula | C18H18O6 |
|---|---|
| Molecular Weight | 330.33200 |
| Exact Mass | 330.11000 |
| PSA | 100.90000 |
| LogP | 2.69120 |